Researchers at the University of Surrey are creating immune digital twins, virtual models of individual immune systems, to advance personalised medicine and deliver tailored treatments.
A breakthrough treatment for severe hay fever caused by birch pollen will soon be available on the NHS, as NICE recommends the first daily immunotherapy tablet for patients who don’t respond to standard therapies.
The UK has approved its first-ever needle-free adrenaline treatment for severe allergic reactions, marking a major development in how anaphylaxis could be managed in emergencies.
The NHS will offer a long-acting antibody injection to protect thousands of premature and vulnerable babies from respiratory syncytial virus (RSV) starting this autumn.
The NHS will provide a new triple combination therapy to hundreds of children and adults with cystic fibrosis in England, aiming to improve lung function and quality of life for eligible patients.
UC Berkeley scientists unveil a powerful new at-home test using nanotech and AI to detect diseases like COVID-19 and cancer with unprecedented sensitivity.
The MHRA has executed a significant operation, seizing a staggering 7.7 million doses of illegal medicines and eliminating hundreds of illicit online listings.
Cardiff University spin-out Draig Therapeutics has been awarded £107m ($140m) to advance the development of novel therapies for major neuropsychiatric disorders.
A revolutionary STI test developed by UK-based Linear Diagnostics, a University of Birmingham spin-out company, delivers lab-accurate results in five minutes.
An 'AI scientist', working in collaboration with human scientists, has discovered that combinations of cheap and safe drugs could be effective at treating breast cancer.
In a groundbreaking first, psilocybin is entering gastroenterology. Dr. Erin Mauney leads a pioneering study exploring how psychedelic therapy could transform treatment for millions suffering from treatment-resistant Irritable Bowel Syndrome, offering new hope for gut-brain disorders.
